Biocon and Equillium expand exclusive licensing agreement for Itolizumab to include Australia and… EP News Bureau Dec 13, 2019 Equillium had originally secured exclusive rights to develop and commercialize Biocon’s novel biologic, itolizumab, for the US and…
Sun Pharma and CMS enter into a License Agreement for Cyclosporine A and Tildrakizumab in Greater… EP News Bureau Jun 27, 2019 Under the terms of the license agreement, CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone…
